Loading clinical trials...
Loading clinical trials...
A Phase 1, Multicenter, Randomized, Double-blind, Double-dummy, Placebo- and Positive-controlled, 4-period Crossover Study to Evaluate the Effect of a Single Dose of Balinatunfib on Cardiac Repolarization in Healthy Adult Participants.
Conditions
Interventions
Balinatunfib
Moxifloxacin
+1 more
Locations
2
United States
FORTREA CLINICAL RESEARCH UNIT INC- Site Number : 8400002
Dallas, Texas, United States
FORTREA CLINICAL RESEARCH UNIT INC- Site Number : 8400001
Madison, Wisconsin, United States
Start Date
December 4, 2025
Primary Completion Date
April 27, 2026
Completion Date
April 27, 2026
Last Updated
January 13, 2026
NCT07310264
NCT06342713
NCT07472361
NCT06823947
NCT06649110
NCT07240675
Trial Transparency email recommended (Toll free for US & Canada)
CONTACT
800-633-1610Contact-US@sanofi.comLead Sponsor
Sanofi
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions